Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1128

1.

Homograft Versus Conventional Prosthesis for Surgical Management of Aortic Valve Infective Endocarditis: A Systematic Review and Meta-analysis.

Yanagawa B, Mazine A, Tam DY, Jüni P, Bhatt DL, Spindel S, Puskas JD, Verma S, Friedrich JO.

Innovations (Phila). 2018 May/Jun;13(3):163-170. doi: 10.1097/IMI.0000000000000510.

PMID:
29912740
2.

High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial.

Vardeny O, Udell JA, Joseph J, Farkouh ME, Hernandez AF, McGeer AJ, Talbot HK, Bhatt DL, Cannon CP, Goodman SG, Anand I, DeMets DL, Temte J, Wittes J, Nichol K, Yancy CW, Gaziano JM, Cooper LS, Kim K, Solomon SD.

Am Heart J. 2018 May 23;202:97-103. doi: 10.1016/j.ahj.2018.05.007. [Epub ahead of print]

PMID:
29909156
3.

Reduced-Intensity Anticoagulation for Mechanical Aortic Valve Prostheses.

Whitlock RP, Bhatt DL, Eikelboom JW.

J Am Coll Cardiol. 2018 Jun 19;71(24):2727-2730. doi: 10.1016/j.jacc.2018.04.018. No abstract available.

PMID:
29903345
4.

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial.

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Bansilal S, Bhatt DL, Leiter LA, McGuire DK, Wilding JP, Gause-Nilsson IA, Langkilde AM, Johansson PA, Sabatine MS.

Am Heart J. 2018 Jun;200:83-89. doi: 10.1016/j.ahj.2018.01.012. Epub 2018 Feb 7.

PMID:
29898853
5.

A Hospital Level Analysis of 30-Day Readmission Performance for Heart Failure Patients and Long-Term Survival: Findings from Get With The Guidelines-Heart Failure.

Jalnapurkar S, Zhao X, Heidenreich PA, Bhatt DL, Smith EE, DeVore AD, Hernandez AF, Matsouaka R, Yancy CW, Fonarow GC.

Am Heart J. 2018 Jun;200:127-133. doi: 10.1016/j.ahj.2017.11.018. Epub 2018 Jan 8.

PMID:
29898841
6.

Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?

Schmaier AA, Bhatt DL.

J Am Heart Assoc. 2018 Jun 1;7(11). pii: e009564. doi: 10.1161/JAHA.118.009564. No abstract available.

7.

Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data Registry.

Udell JA, Desai NR, Li S, Thomas L, de Lemos JA, Wright-Slaughter P, Zhang W, Roe MT, Bhatt DL.

Circ Cardiovasc Qual Outcomes. 2018 Jun;11(6):e004054. doi: 10.1161/CIRCOUTCOMES.117.004054.

PMID:
29848476
8.

Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study.

Si S, Golledge J, Norman P, Nelson M, Chew D, Ademi Z, Bhatt DL, Steg GP, Reid CM.

Heart Lung Circ. 2018 May 8. pii: S1443-9506(18)30463-3. doi: 10.1016/j.hlc.2018.04.292. [Epub ahead of print]

PMID:
29843973
9.

Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo.

Wadhera RK, Joynt Maddox KE, Yeh RW, Bhatt DL.

JAMA Cardiol. 2018 May 9. doi: 10.1001/jamacardio.2018.0947. [Epub ahead of print]

PMID:
29800962
10.

Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment.

McCarthy CP, Vaduganathan M, McCarthy KJ, Januzzi JL Jr, Bhatt DL, McEvoy JW.

JAMA Cardiol. 2018 May 9. doi: 10.1001/jamacardio.2018.1086. [Epub ahead of print]

PMID:
29800958
11.

Percutaneous Coronary Intervention in 2018.

Bhatt DL.

JAMA. 2018 May 22;319(20):2127-2128. doi: 10.1001/jama.2018.5281. Review. No abstract available.

PMID:
29800163
12.

Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States.

Man S, Zhao X, Uchino K, Hussain MS, Smith EE, Bhatt DL, Xian Y, Schwamm LH, Shah S, Khan Y, Fonarow GC.

Circ Cardiovasc Qual Outcomes. 2018 Jun;11(6):e004512. doi: 10.1161/CIRCOUTCOMES.117.004512.

PMID:
29794035
13.

Reply: Cardiovascular Risk Models and Statin Therapy.

Singh A, DiCarli MF, Nasir K, Bhatt DL, Blankstein R.

J Am Coll Cardiol. 2018 May 29;71(21):2491-2492. doi: 10.1016/j.jacc.2018.03.487. No abstract available.

PMID:
29793640
14.

Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances.

Hussain MA, Al-Omran M, Creager MA, Anand SS, Verma S, Bhatt DL.

J Am Coll Cardiol. 2018 May 29;71(21):2450-2467. doi: 10.1016/j.jacc.2018.03.483. Review.

PMID:
29793635
15.

The Reply.

Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL.

Am J Med. 2018 Jun;131(6):e267-e268. doi: 10.1016/j.amjmed.2017.12.043. No abstract available.

PMID:
29784198
16.

The Reply.

Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL.

Am J Med. 2018 Jun;131(6):e263. doi: 10.1016/j.amjmed.2018.01.044. No abstract available.

PMID:
29784196
17.

Real-world revascularization therapy in heart failure: It's a jungle out there!

Zenati MA, Bhatt DL.

J Thorac Cardiovasc Surg. 2018 Apr 24. pii: S0022-5223(18)31207-8. doi: 10.1016/j.jtcvs.2018.04.070. [Epub ahead of print] No abstract available.

PMID:
29778338
18.

Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.

Verma S, Bhatt DL, Bain SC, Buse JB, Mann JFE, Marso SP, Nauck MA, Poulter NR, Pratley RE, Zinman B, Michelsen MM, Monk Fries T, Rasmussen S, Leiter LA; LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Circulation. 2018 May 15;137(20):2179-2183. doi: 10.1161/CIRCULATIONAHA.118.033898. No abstract available.

PMID:
29760228
19.

Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.

Brilakis ES, Edson R, Bhatt DL, Goldman S, Holmes DR Jr, Rao SV, Shunk K, Rangan BV, Mavromatis K, Ramanathan K, Bavry AA, Garcia S, Latif F, Armstrong E, Jneid H, Conner TA, Wagner T, Karacsonyi J, Uyeda L, Ventura B, Alsleben A, Lu Y, Shih MC, Banerjee S; DIVA Trial Investigators.

Lancet. 2018 May 19;391(10134):1997-2007. doi: 10.1016/S0140-6736(18)30801-8. Epub 2018 May 11.

PMID:
29759512
20.

Emerging Transcatheter Options for Tricuspid Regurgitation.

Kalra A, Uberoi AS, Latib A, Khera S, Little SH, Bhatt DL, Reardon MJ, Kleiman NS, Barker CM.

Methodist Debakey Cardiovasc J. 2017 Jul-Sep;13(3):120-125. doi: 10.14797/mdcj-13-3-120. Review.

21.

Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.

Tamez H, Généreux P, Yeh RW, Amin AP, Fan W, White HD, Kirtane AJ, Stone GW, Gibson CM, Harrington RA, Bhatt DL, Pinto DS; CHAMPION PHOENIX ECONOMICS Investigators.

Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27638. [Epub ahead of print]

PMID:
29726596
22.

Trends in utilization of mechanical circulatory support in patients hospitalized after out-of-hospital cardiac arrest.

Patel NJ, Patel N, Bhardwaj B, Golwala H, Kumar V, Atti V, Arora S, Patel S, Patel N, Hernandez GA, Badheka A, Alfonso CE, Cohen MG, Bhatt DL, Kapur NK.

Resuscitation. 2018 Jun;127:105-113. doi: 10.1016/j.resuscitation.2018.04.007. Epub 2018 Apr 16.

PMID:
29674141
23.

Percutaneous Closure of Patent Foramen Ovale in Migraine: A Meta-Analysis of Randomized Clinical Trials.

Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G, Bhatt DL.

JACC Cardiovasc Interv. 2018 Apr 23;11(8):816-818. doi: 10.1016/j.jcin.2018.01.232. No abstract available.

PMID:
29673517
24.

Rediscovering the Orbit of Percutaneous Coronary Intervention After ORBITA.

Bhatt DL, Gersh BJ, Steg PG, Harrington RA, Windecker S.

Circulation. 2018 Jun 5;137(23):2427-2429. doi: 10.1161/CIRCULATIONAHA.118.034596. Epub 2018 Apr 18. No abstract available.

PMID:
29669787
25.

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.

Golwala HB, Cannon CP, Steg PG, Doros G, Qamar A, Ellis SG, Oldgren J, Ten Berg JM, Kimura T, Hohnloser SH, Lip GYH, Bhatt DL.

Eur Heart J. 2018 May 14;39(19):1726-1735a. doi: 10.1093/eurheartj/ehy162.

26.

Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease.

Baibhav B, Gedela M, Moulton M, Pavlides G, Pompili V, Rab T, Dangas G, Bhatt DL, Siddique A, Chatzizisis YS.

Circulation. 2018 Apr 17;137(16):1731-1739. doi: 10.1161/CIRCULATIONAHA.117.031182. Review.

PMID:
29661951
27.

Medicare Expenditures by Race/Ethnicity After Hospitalization for Heart Failure With Preserved Ejection Fraction.

Ziaeian B, Heidenreich PA, Xu H, DeVore AD, Matsouaka RA, Hernandez AF, Bhatt DL, Yancy CW, Fonarow GC.

JACC Heart Fail. 2018 May;6(5):388-397. doi: 10.1016/j.jchf.2017.12.007. Epub 2018 Apr 11.

PMID:
29655830
28.

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital Outcomes.

Gupta T, Khera S, Kolte D, Goel K, Kalra A, Villablanca PA, Aronow HD, Abbott JD, Fonarow GC, Taub CC, Kleiman NS, Weisz G, Inglessis I, Elmariah S, Rihal CS, Garcia MJ, Bhatt DL.

Circ Cardiovasc Interv. 2018 Apr;11(4):e006179. doi: 10.1161/CIRCINTERVENTIONS.117.006179.

PMID:
29643130
29.

Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).

Groves EM, Bhatt DL, Steg PG, Deliargyris EN, Stone GW, Gibson CM, Hamm CW, Mahaffey KW, White HD, Angiolillo D, Prats J, Harrington RA, Price MJ.

Circ Cardiovasc Interv. 2018 Apr;11(4):e005635. doi: 10.1161/CIRCINTERVENTIONS.117.005635.

PMID:
29632238
30.

Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study.

Wise RA, Chapman KR, Scirica BM, Schoenfeld DA, Bhatt DL, Daoud SZ, Seoane B, Reisner C, Garcia Gil E.

Chronic Obstr Pulm Dis. 2018 Jan 24;5(1):5-15. doi: 10.15326/jcopdf.5.1.2017.0149.

31.

Sex and Racial Disparities in Cardiac Rehabilitation Referral at Hospital Discharge and Gaps in Long-Term Mortality.

Li S, Fonarow GC, Mukamal K, Xu H, Matsouaka RA, Devore AD, Bhatt DL.

J Am Heart Assoc. 2018 Apr 6;7(8). pii: e008088. doi: 10.1161/JAHA.117.008088.

32.

Lack of Association Between Heart Failure and Incident Cancer.

Selvaraj S, Bhatt DL, Claggett B, Djoussé L, Shah SJ, Chen J, Imran TF, Qazi S, Sesso HD, Gaziano JM, Schrag D.

J Am Coll Cardiol. 2018 Apr 10;71(14):1501-1510. doi: 10.1016/j.jacc.2018.01.069.

PMID:
29622155
33.

Is There Really a Benefit to Net Clinical Benefit in Testing Antithrombotics?

Steg PG, Bhatt DL.

Circulation. 2018 Apr 3;137(14):1429-1431. doi: 10.1161/CIRCULATIONAHA.117.033442. No abstract available.

PMID:
29610124
34.

Association of Electronic Health Record Use With Quality of Care and Outcomes in Heart Failure: An Analysis of Get With The Guidelines-Heart Failure.

Selvaraj S, Fonarow GC, Sheng S, Matsouaka RA, DeVore AD, Heidenreich PA, Hernandez AF, Yancy CW, Bhatt DL.

J Am Heart Assoc. 2018 Mar 30;7(7). pii: e008158. doi: 10.1161/JAHA.117.008158.

35.

Aortic Valve Replacement in an Era of Rapid Innovation: Better the Devil You Know.

Fedak PWM, Bhatt DL, Verma S.

J Am Coll Cardiol. 2018 Apr 3;71(13):1413-1416. doi: 10.1016/j.jacc.2018.02.007. No abstract available.

PMID:
29598860
36.

Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction.

Echouffo-Tcheugui JB, Kolte D, Khera S, Aronow HD, Abbott JD, Bhatt DL, Fonarow GC.

Am J Med. 2018 Jul;131(7):778-786.e1. doi: 10.1016/j.amjmed.2018.03.004. Epub 2018 Mar 27.

PMID:
29596788
37.

External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.

Williams BA, Chagin KM, Bash LD, Boden WE, Duval S, Fowkes FGR, Mahaffey KW, Patel MD, D'Agostino RB, Peterson ED, Kattan MW, Bhatt DL, Bonaca MP.

Atherosclerosis. 2018 May;272:80-86. doi: 10.1016/j.atherosclerosis.2018.03.026. Epub 2018 Mar 16.

PMID:
29579671
38.

Biomarkers enter the world of peripheral artery disease.

Majithia A, Bhatt DL.

Eur Heart J. 2018 Mar 22. doi: 10.1093/eurheartj/ehy108. [Epub ahead of print] No abstract available.

PMID:
29579280
39.

Moving towards personalised antiplatelet therapy after PCI using risk scores.

Peterson BE, Bhatt DL.

EuroIntervention. 2018 Mar 20;13(16):1861-1863. doi: 10.4244/EIJV13I16A302. No abstract available.

40.

12 months of DAPT after acute coronary syndrome still beats 6 months.

Motovska Z, Bhatt DL.

Lancet. 2018 Mar 31;391(10127):1240-1242. doi: 10.1016/S0140-6736(18)30612-3. Epub 2018 Mar 12. No abstract available.

PMID:
29544700
41.

Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.

Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, Abola MT, Branch KRH, Keltai K, Bhatt DL, Verhamme P, Fox KAA, Cook-Bruns N, Lanius V, Connolly SJ, Yusuf S.

J Am Coll Cardiol. 2018 May 22;71(20):2306-2315. doi: 10.1016/j.jacc.2018.03.008. Epub 2018 Mar 11.

PMID:
29540326
42.

Contemporary parenteral antiplatelet bridging strategies: a single-centre real-world experience at a tertiary care centre.

Stern G, Rimsans J, Qamar A, Vaduganathan M, Bhatt DL.

EuroIntervention. 2018 Jun 8;14(3):333-335. doi: 10.4244/EIJ-D-18-00036. No abstract available.

43.

Cocaine and Marijuana Use Among Young Adults With Myocardial Infarction.

DeFilippis EM, Singh A, Divakaran S, Gupta A, Collins BL, Biery D, Qamar A, Fatima A, Ramsis M, Pipilas D, Rajabi R, Eng M, Hainer J, Klein J, Januzzi JL, Nasir K, Di Carli MF, Bhatt DL, Blankstein R.

J Am Coll Cardiol. 2018 Jun 5;71(22):2540-2551. doi: 10.1016/j.jacc.2018.02.047. Epub 2018 Mar 10.

PMID:
29535062
44.

Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry.

Pandey A, Patel KV, Liang L, DeVore AD, Matsouaka R, Bhatt DL, Yancy CW, Hernandez AF, Heidenreich PA, de Lemos JA, Fonarow GC.

JAMA Cardiol. 2018 Jun 1;3(6):489-497. doi: 10.1001/jamacardio.2018.0579.

PMID:
29532056
45.

Association Between 30-Day Episode Payments and Acute Myocardial Infarction Outcomes Among Medicare Beneficiaries.

Wadhera RK, Joynt Maddox KE, Wang Y, Shen C, Bhatt DL, Yeh RW.

Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004397. doi: 10.1161/CIRCOUTCOMES.117.004397.

PMID:
29530887
46.

Sustained sex-based treatment differences in acute coronary syndrome care: Insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry.

Udell JA, Fonarow GC, Maddox TM, Cannon CP, Frank Peacock W, Laskey WK, Grau-Sepulveda MV, Smith EE, Hernandez AF, Peterson ED, Bhatt DL; Get With The Guidelines Steering Committee and Investigators.

Clin Cardiol. 2018 Jun;41(6):758-768. doi: 10.1002/clc.22938. Epub 2018 May 11.

47.

Segmental Arterial Mediolysis: An Important but Often Overlooked Cause of Multi-Vessel Thrombosis.

Carroll BJ, Steigner ML, Priya S, Bhatt DL, Maron BA.

Am J Med. 2018 Jun;131(6):e231-e234. doi: 10.1016/j.amjmed.2018.01.057. Epub 2018 Mar 2. No abstract available.

PMID:
29505754
48.

CABG the clear choice for patients with diabetes and multivessel disease.

Bhatt DL.

Lancet. 2018 Mar 10;391(10124):913-914. doi: 10.1016/S0140-6736(18)30424-0. Epub 2018 Feb 23. No abstract available.

PMID:
29478842
49.

Bivalirudin versus unfractionated heparin in peripheral vascular interventions.

Omran J, Enezate T, Abdullah O, Al-Dadah AS, Aronow HD, Mustapha J, Saab F, Brilakis ES, Reeves RR, Bhatt DL, Mahmud E.

Cardiovasc Revasc Med. 2018 Jan 31. pii: S1553-8389(18)30012-5. doi: 10.1016/j.carrev.2018.01.010. [Epub ahead of print]

PMID:
29477790
50.

Supplemental Content

Loading ...
Support Center